UnknownNCT00436774
Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Cancer and Leukaemia Group
- Principal Investigator
- Adam Glaser, MDLeeds Cancer Centre at St. James's University Hospital
- Intervention
- assessment of therapy complications(procedure)
- Enrollment
- 60 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2006
Study locations (13)
- Our Lady's Hospital for Sick Children Crumlin, Dublin, Ireland
- Institute of Child Health at University of Bristol, Bristol, England, United Kingdom
- Addenbrooke's Hospital, Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
- Great Ormond Street Hospital for Children, London, England, United Kingdom
- Sir James Spence Institute of Child Health at Royal Victoria Infirmary, Newcastle upon Tyne, England, United Kingdom
- Children's Hospital - Sheffield, Sheffield, England, United Kingdom
- Southampton General Hospital, Southampton, England, United Kingdom
- Royal Marsden - Surrey, Sutton, England, United Kingdom
- Royal Aberdeen Children's Hospital, Aberdeen, Scotland, United Kingdom
- Royal Hospital for Sick Children, Edinburgh, Scotland, United Kingdom
- Royal Hospital for Sick Children, Glasgow, Scotland, United Kingdom
- Childrens Hospital for Wales, Cardiff, Wales, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00436774 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology